Nonsense Tx

🗓 Founded 2023👥 2 employees
Biotechnology Research🌐 nonsensetx.com
Website LinkedIn
Nonsense mutations cause about 10-12% of cases across over 10,000 rare diseases, impacting roughly 40 million people. These mutations often lead to the most severe disease outcomes. At Nonsense Tx, we focus on developing small-molecule therapies to boost collagen 7 production for Dystrophic EB patients. Early lab results using primary patient cells—tested with a leading expert on nonsense mutations in EB—have shown very promising outcomes
0
Total investors
0
Early stage
0
Mid stage
0
Late stage
2023
Founded

Investors

0 investors
All
Early stage
Mid stage
Late stage
No investors in this category
Frequently asked questions
When was Nonsense Tx founded?
Nonsense Tx was founded in 2023.
What industry is Nonsense Tx in?
Nonsense Tx operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.